scispace - formally typeset
J

Jiangwen Zhang

Researcher at University of Hong Kong

Publications -  66
Citations -  11875

Jiangwen Zhang is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Cancer & Adipogenesis. The author has an hindex of 41, co-authored 62 publications receiving 9790 citations. Previous affiliations of Jiangwen Zhang include Johns Hopkins University School of Medicine & Harvard University.

Papers
More filters
Journal ArticleDOI

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

TL;DR: It is found that PTENP1 is biologically active as it can regulate cellular levels of PTEN and exert a growth-suppressive role, and this analysis extended to other cancer-related genes that possess pseudogenes, and revealed a non-coding function for mRNAs.
Journal ArticleDOI

The MicroRNA miR-124 Promotes Neuronal Differentiation by Triggering Brain-Specific Alternative Pre-mRNA Splicing

TL;DR: Neuron-specific microRNA miR-124 promotes NS development, at least in part by regulating an intricate network of NS-specific alternative splicing patterns.
Journal ArticleDOI

TISIDB: an integrated repository portal for tumor-immune system interactions

TL;DR: A user-friendly web portal TISIDB is designed, which integrated multiple types of data resources in oncoimmunology, and biologists can cross-check a gene of interest about its role in tumor-immune interactions through literature mining and high-throughput data analysis.
Journal ArticleDOI

SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization

TL;DR: It is shown that the mitochondrial NAD-dependent deacetylase SIRT3 is a crucial regulator of the Warburg effect, and it is found that Sirt3 overexpression represses glycolysis and proliferation in breast cancer cells, providing a metabolic mechanism for tumor suppression.
Journal ArticleDOI

Subtle variations in Pten dose determine cancer susceptibility

TL;DR: An alterative working model for cancer development is presented in which subtle reductions in the dose of TSGs predispose to tumorigenesis in a tissue-specific manner and subtle downregulation of Pten altered the steady-state biology of the mammary tissues and the expression profiles of genes involved in cancer cell proliferation.